Acute lymphoblastic leukemia (ALL) is a rare type of blood cancer caused due to the overproduction of lymphocytes by the bone marrow in the human body. It is one of the common types of cancer in children, which has a fair chance of being cured. However, this may even occur in adults, and the chances of a cure are slim if diagnosed at a later stage. To aid in the early detection of this deadly disease, an intelligent method to screen the white blood cells is proposed in this study. The proposed intelligent deep learning algorithm uses the microscopic images of blood smears as the input data. This algorithm is implemented with a convolutional neural network (CNN) to predict the leukemic cells from the healthy blood cells. The custom ALLNET model was trained and tested using the microscopic images available as open-source data. The model training was carried out on Google Collaboratory using the Nvidia Tesla P-100 GPU method. Maximum accuracy of 95.54%, specificity of 95.81%, sensitivity of 95.91%, F1-score of 95.43%, and precision of 96% were obtained by this accurate classifier. The proposed technique may be used during the pre-screening to detect the leukemia cells during complete blood count (CBC) and peripheral blood tests.
Sickle cell disease (SCD), a blood disorder that transforms the shape of red blood cells into a distinctive sickle form, is a major concern as it not only compromises the blood’s oxygen-carrying capacity but also poses significant health risks, ranging from weakness to paralysis and, in severe cases, even fatality. This condition not only underscores the pressing need for innovative solutions but also encapsulates the broader challenges faced by medical professionals, including delayed treatment, protracted processes, and the potential for subjective errors in diagnosis and classification. Consequently, the application of artificial intelligence (AI) in healthcare has emerged as a transformative force, inspiring multidisciplinary efforts to overcome the complexities associated with SCD and enhance diagnostic accuracy and treatment outcomes. The use of transfer learning helps to extract features from the input dataset and give an accurate prediction. We analyse and compare the performance parameters of three distinct models for this purpose: GoogLeNet, ResNet18, and ResNet50. The best results were shown by the ResNet50 model, with an accuracy of 94.90%. Explainable AI is the best approach for transparency and confirmation of the predictions made by the classifiers. This research utilizes Grad-CAM to interpret and make the models more reliable. Therefore, this specific approach benefits pathologists through its speed, precision, and accuracy of classification of sickle cells.
Dengue fever, also known as break-bone fever, can be life-threatening. Caused by DENV, an RNA virus from the Flaviviridae family, dengue is currently a globally important public health problem. The clinical methods available for dengue diagnosis require skilled supervision. They are manual, time-consuming, labor-intensive, and not affordable to common people. This paper describes a method that can support clinicians during dengue diagnosis. It is proposed to automate the peripheral blood smear (PBS) examination using Artificial Intelligence (AI) to aid dengue diagnosis. Nowadays, AI, especially Machine Learning (ML), is increasingly being explored for successful analyses in the biomedical field. Digital pathology coupled with AI holds great potential in developing healthcare services. The automation system developed incorporates a blob detection method to detect platelets and thrombocytopenia from the PBS images. The results achieved are clinically acceptable. Moreover, an ML-based technique is proposed to detect dengue from the images of PBS based on the lymphocyte nucleus. Ten features are extracted, including six morphological and four Gray Level Spatial Dependance Matrix (GLSDM) features, out of the lymphocyte nucleus of normal and dengue cases. Features are then subjected to various popular supervised classifiers built using a ten-fold cross-validation policy for automated dengue detection. Among all the classifiers, the best performance was achieved by Support Vector Machine (SVM) and Decision Tree (DT), each with an accuracy of 93.62%. Furthermore, 1000 deep features extracted using pre-trained MobileNetV2 and 177 textural features extracted using Local binary pattern (LBP) from the lymphocyte nucleus are subjected to feature selection. The ReliefF selected 100 most significant features are then fed to the classifiers. The best performance was attained using an SVM classifier with 95.74% accuracy. With the obtained results, it is evident that this proposed approach can efficiently contribute as an adjuvant tool for diagnosing dengue from the digital microscopic images of PBS.
A digital microscope plays a crucial role in the better and faster diagnosis of an abnormality using various techniques. There has been significant development in this domain of digital pathology. Sickle cell disease (SCD) is a genetic disorder that affects hemoglobin in red blood cells. The traditional method for diagnosing sickle cell disease involves preparing a glass slide and viewing the slide using the eyepiece of a manual microscope. The entire process thus becomes very tedious and time consuming. This paper proposes a semi-automated system that can capture images based on a predefined program. It has an XY stage for moving the slide horizontally or vertically and a Z stage for focus adjustments. The case study taken here is of SCD. The proposed hardware captures SCD slides, which are further used to classify them with respect to normal. They are processed using deep learning models such as Darknet-19, ResNet50, ResNet18, ResNet101, and GoogleNet. The tested models demonstrated strong performance, with most achieving high metrics across different configurations varying with an average of around 97%. In the future, this semi-automated system will benefit pathologists and can be used in rural areas, where pathologists are in short supply.
Dengue fever is a rapidly increasing mosquito-borne ailment spread by the virus DENV in the tropics and subtropics worldwide. It is a significant public health problem and accounts for many deaths globally. Implementing more effective methods that can more accurately detect dengue cases is challenging. The theme of this digital pathology-associated research is automatic dengue detection from peripheral blood smears (PBS) employing deep learning (DL) techniques. In recent years, DL has been significantly employed for automated computer-assisted diagnosis of various diseases from medical images. This paper explores pre-trained convolution neural networks (CNNs) for automatic dengue fever detection. Transfer learning (TL) is executed on three state-of-the-art CNNs – ResNet50, MobileNetV3Small, and MobileNetV3Large, to customize the models for differentiating the dengue-infected blood smears from the healthy ones. The dataset used to design and test the models contains 100x magnified dengue-infected and healthy control digital microscopic PBS images. The models are validated with a 5-fold cross-validation framework and tested on unseen data. An explainable artificial intelligence (XAI) approach, Gradient-weighted Class Activation Mapping (GradCAM), is eventually applied to the models to allow visualization of the precise regions on the smears most instrumental in making the predictions. While all three transferred pre-trained CNN models performed well (above 98% overall classification accuracy), MobileNetV3Small is the recommended model for this classification problem due to its significantly less computationally demanding characteristics. Transferred pre-trained CNN based on MobileNetV3Small yielded Accuracy, Recall, Specificity, Precision, F1 Score, and Area Under the ROC Curve (AUC) of 0.982 ± 0.011, 0.973 ± 0.027, 0.99 ± 0.013, 0.989 ± 0.015, 0.981 ± 0.012 and 0.982 ± 0.012 respectively, averaged over the five folds on the unseen dataset. Promising results show that the developed models have the potential to provide high-quality support to haematologists by expertly performing tedious, repetitive, and time-consuming tasks in hospitals and remote/low-resource settings.